A Randomized Placebo-controlled, Double Blind Phase 2 Clinical Trial of Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus
Phase of Trial: Phase II
Latest Information Update: 03 Oct 2018
Price : $35 *
At a glance
- Drugs Memantine (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
- Acronyms ClearMEMory
- 03 Oct 2018 Last checked against ClinicalTrials.gov.
- 24 Sep 2018 Status changed from not yet recruiting to recruiting.
- 17 Jul 2018 Planned initiation date changed from 1 May 2018 to 1 Aug 2018.